Thursday, January 20, 2022

Expert skeptical about vaccines

Dr. Peter McCullough – a renowned cardiologist and highly published medical scientist whose confrontation of the government's COVID-19 policies has drawn more than 40 million views on Joe Rogan's podcast – told WND in a video interview Thursday night the official pandemic narrative that has been fiercely guarded by establishment media and social-media censors is "completely crumbling."

That narrative, he said, included "false statements regarding asymptomatic spread, reliance on lockdown and masks – which obviously didn't work – the suppression of early treatment, the mass promotion of vaccines that failed."

"And now here we are, almost in complete free fall," McCullough said, referring to the record number of COVID-19 cases as officials acknowledge the vaccines don't prevent infection or transmission.

McCullough noted that in California, with the more contagious but much milder omicron variant now dominant, health care workers who tested positive for COVID-19 and had symptoms were told to go back to work.

"With that, I think that's it. I think that's the end. The narrative has crumbled. People don't want these vaccines," McCullough said. "The vaccines should be pulled off the market. They clearly are not solving the problem."

The focus, he said, should be on "treating high-risk patients who develop symptoms" with some of the early treatments that he and other physicians around the world have found to be effective, including ivermectin and a new drug granted emergency use authorization by the FDA, Paxlovid.

McCullough cited a study from Denmark and data from the U.K.'s health agency showing that the vaccines have zero effectiveness against omicron.

Completing this poll entitles you to WND news updates free of charge. You may opt out at anytime. You also agree to our Privacy Policy and Terms of Use.

"That's not misinformation," he said. "I'm just quoting the data. All of this can be looked up. Fact-checkers can look at it. I know I'll never have any problems with allegations of misinformation, because I just quote the data."

President Biden clearly had McCullough in mind when on Thursday he urged social media companies and media outlets to "please deal with the misinformation and disinformation that's on your shows. It has to stop."

McCullough pointed out his work has been relied upon by courts across the nation, including the U.S. Supreme Court, and he has testified to the U.S. Senate and will be back there later this month.


Fourth shot of Covid vaccine is NOT enough against Omicron

Even a fourth dose of current Covid vaccines is not enough to prevent Omicron infection, according to preliminary results from a trial in Israel.

The study of more than 270 medical staff found that the fourth shot only raised antibodies 'a little' compared to those who were triple-jabbed.

And those in the four jabs group were only 'a bit less' likely to test positive for the mutant strain than the control group.

The findings were true for a fourth dose of both Pfizer and Moderna, and will reignite the debate about whether constant boosting is necessary.

Researchers from the Sheba Medical Center in Tel Aviv, who ran the trial, said those infected in the study had very mild symptoms or none at all.

Dr. Gili Regev-Yochay, the lead researcher of the trial, told a press conference: 'These are very preliminary results. This is before any publication.

'But we're giving it out since we understand the urgency of the public to get any information possible about the fourth dose.'

The findings will likely reignite the debate around how often Covid vaccine boosters are needed.

A UK Government adviser today became the latest senior figure to warn against repeated mass vaccinations, recommending a targeted approach like for flu.

And last week, European Union regulators claimed that boosting too frequently could actually weaken the immune system.

The World Health Organization has called on vaccine makers to make variant-proof jabs to avoid countries having to revaccinate every few months.

Israel was the first country in the world to roll out boosters last year and became the only nation to start dishing out fourth shots last month to combat Omicron.

Studies have since shown that three jabs are holding up well against serious illness, offering about 88 per cent protection from hospitalisation, even if Omicron can slip past the immune system and cause an infection more easily.

More than half a million people in those two risk groups have been quadruple-jabbed so far. But she admitted the small extra benefit was not enough to justify a wider rollout to the whole adult population.


Blood thinner could be used to treat and stop transmission of COVID-19

Patients at four hospitals in NSW and Victoria are set to undergo treatment with a cheap, readily available drug that scientists believe can dramatically improve outcomes for those infected with COVID-19.

Heparin is a common blood thinner that has been in use for decades. Australian National University researchers are coordinating multiple studies aiming to prove it is effective in preventing severe disease among coronavirus patients when inhaled directly into the lungs.

ANU study lead Professor Frank van Haren said initial results indicate the drug could be “a promising treatment” and also “a possible preventative against the virus” with breathing and oxygen levels improving in 70 per cent of patients after they inhaled a course of heparin.

“If it is as effective as our early results suggest, it could have a major impact in our fight against COVID,” Professor van Haren said.

Researchers around the world are tracking hospital patients infected with SARS-CoV-2 in 13 countries who were given doses of inhaled heparin, which is administered through an inhaler similar to the ones used to treat asthma.

When the study began, Australia did not have enough people infected with COVID-19 to test the drug on patients here, but now trials are beginning at St George Hospital in Kogarah, the John Hunter Hospital in Newcastle, Sydney’s Royal North Shore Hospital and St Vincent’s Melbourne.

A randomised, peer reviewed study of 98 patients, to be published in the British Journal of Clinical Pharmacology on Thursday, found heparin was safe, with no concerning side effects among patients who inhaled a therapeutic dose of the drug.

While the larger, ongoing international study would provide a “definitive” answer about the treatment’s efficacy, Professor van Haren said the new safety findings were crucial.

“It’s super important to know that the new treatment and new way of giving something is actually safe, that it doesn’t do any harm,” he said. “There is still an urgent need for an effective treatment of COVID-19.”

Co-author Professor Clive Page, from King’s College London, who is co-leading the global studies, said inhaled heparin had antiviral properties “which work by binding to the spike proteins the coronavirus uses to enter the cells of the body.”

“Inhaled heparin effectively stops the virus infecting cells in the lungs and could also stop people from getting the virus from others,” Professor Page said.

“It also works as an anti-inflammatory drug; the medicine has the ability to calm everything down when the body is mounting an exaggerated response to the virus.”

Professor van Haren said he hoped the drug’s efficacy could be proven quickly, saying it could be used widely within months if early results held up – easing the strain on hospitals by reducing the number of patients needing to be admitted to intensive care units.

“Most COVID experts agree that vaccination alone is not going to stop the pandemic. This could really assist in poorer countries where vaccination is challenging and we think it could help frontline workers who could use it as a preventative measure,” he said.

Professor van Haren said the team was now collecting more evidence that inhaled heparin worked and that “once we have this evidence, heparin via inhalation, could be an option to treat COVID-19 patients, everywhere, within months”.

Heparin, which is normally administered via injection, is a blood thinner used to treat and prevent blood clots across the world and is widely available.




No comments: